Cardinal Health, Inc. (CAH) Interest Coverage Ratio: 10.58x
The interest coverage ratio for Cardinal Health, Inc. (CAH) is 10.58x as of Tuesday, June 16, 2026.
CAH Interest Coverage Ratio Metrics
INTEREST COVERAGE RATIO
10.58x
CAH Competitors' Interest Coverage Ratio
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cardinal Health, Inc. (CAH) | $53.55B | 10.58x | N/A | N/A | N/A |
| Becton, Dickinson and Company (BDX)vs › | $52.59B | 4.21x | 4.38x | 4.79x | 4.28x |
| Cencora, Inc. (COR)vs › | $54.76B | 8.69x | 10.46x | 10.41x | 11.51x |
| Humana Inc. (HUM)vs › | $45.03B | 2.30x | 2.38x | 5.10x | 7.90x |
| IDEXX Laboratories, Inc. (IDXX)vs › | $44.83B | 35.54x | 35.85x | 30.16x | 28.81x |
| Regeneron Pharmaceuticals, Inc. (REGN)vs › | $62.78B | 81.69x | 77.00x | 76.06x | 87.20x |
| Boston Scientific Corporation (BSX)vs › | $69.74B | 11.38x | 9.10x | 7.54x | 6.16x |
| Agilent Technologies, Inc. (A)vs › | $36.58B | 13.21x | 14.36x | 15.54x | 14.94x |
| Zoetis Inc. (ZTS)vs › | $32.87B | 14.80x | 14.41x | 13.27x | 12.34x |
| Medline Inc. (MDLN)vs › | $31.36B | 2.72x | 2.21x | 1.60x | 1.60x |
Financial Health Indicators
Interest Coverage
10.6x
Debt/Equity
-3.36
Current Ratio
0.94
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
- < 1.5x: EBIT is less than 1.5 times interest expense
- 1.5x - 3x: EBIT is between 1.5 and 3 times interest expense
- 3x - 5x: EBIT is between 3 and 5 times interest expense
- > 5x: EBIT is more than 5 times interest expense
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Cardinal Health, Inc. Interest Coverage Ratio Formula & Definition
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Cardinal Health, Inc. Interest Coverage Ratio FAQ
- What is the interest coverage ratio for Cardinal Health, Inc. (CAH)?
- The interest coverage ratio for CAH stock is 10.58x.
About Cardinal Health, Inc.
Cardinal Health, Inc. operates as a global, integrated provider of healthcare services and products, with its reach spanning the United States, Canada, Europe, Asia, and other international markets. The company delivers bespoke support to a diverse clientele, including hospitals, healthcare networks, pharmacies, outpatient surgical centers, clinical labs, physician practices, and individuals receiving care at home. It is structured into two core divisions: Pharmaceutical and Medical. The Pharmaceutical division oversees the distribution of a wide array of products, encompassing branded, generic, and specialty pharmaceuticals, along with over-the-counter health and consumer goods. This segment additionally offers specialized services to pharmaceutical manufacturers and healthcare providers, particularly for specialty pharmaceutical products. Its operations extend to managing nuclear pharmacies and facilities that produce radiopharmaceuticals. It also performs repackaging of generic drugs and OTC items. Further offerings include medication therapy management and patient outcomes services for hospitals, other healthcare providers, and payers, in addition to providing pharmacy management solutions to hospitals. The Medical division focuses on producing, sourcing, and supplying Cardinal Health-branded medical, surgical, and laboratory products and devices. This extensive product range encompasses items such as examination and surgical gloves, needles, syringes, sharps disposal units, compression products, incontinence aids, nutritional delivery systems, wound care supplies, single-use drapes, gowns, and apparel, fluid suction and collection devices, urological products, operating room essentials, and electrodes. Beyond its proprietary brands, this segment also distributes various national brand medical, surgical, and laboratory products. It offers comprehensive supply chain management for hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare organizations, and manufactures and sells both sterile and non-sterile procedure kits. Established in 1979, the company maintains its headquarters in Dublin, Ohio.
- Sector
- Healthcare
- Industry
- Medical - Distribution
- CEO
- Jason Hollar